158 related articles for article (PubMed ID: 37151163)
1. Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
Patel MA; Shah JL; Brinley FJ; Abrahamse PH; Veenstra CM; Schott AF
Cancer Med; 2023 Jun; 12(11):12802-12812. PubMed ID: 37151163
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.
Simon MS; Du W; Flaherty L; Philip PA; Lorusso P; Miree C; Smith D; Brown DR
J Clin Oncol; 2004 Jun; 22(11):2046-52. PubMed ID: 15082724
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults.
Roth M; Beauchemin M; Kahn JM; Bleyer A
Cancer Med; 2021 Nov; 10(21):7620-7628. PubMed ID: 34592782
[TBL] [Abstract][Full Text] [Related]
5. Disparities in phase 1 cancer clinical trial enrollment.
Perni S; Moy B; Nipp RD
Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
[TBL] [Abstract][Full Text] [Related]
6. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
Gross CP; Filardo G; Mayne ST; Krumholz HM
Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
[TBL] [Abstract][Full Text] [Related]
7. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
8. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
[TBL] [Abstract][Full Text] [Related]
9. Predictors of enrollment in lung cancer clinical trials.
Du W; Gadgeel SM; Simon MS
Cancer; 2006 Jan; 106(2):420-5. PubMed ID: 16342295
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
[TBL] [Abstract][Full Text] [Related]
11. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.
Greene SJ; DeVore AD; Sheng S; Fonarow GC; Butler J; Califf RM; Hernandez AF; Matsouaka RA; Samman Tahhan A; Thomas KL; Vaduganathan M; Yancy CW; Peterson ED; O'Connor CM; Mentz RJ
JACC Heart Fail; 2019 Nov; 7(11):980-992. PubMed ID: 31606362
[TBL] [Abstract][Full Text] [Related]
12. Barriers to eligibility and enrollment among older women in a clinical trial on osteoporosis: effects of ethnicity and SES.
Unson CG; Ohannessian C; Kenyon L; Case A; Reisine S; Prestwood K
J Aging Health; 2004 Jun; 16(3):426-43. PubMed ID: 15155070
[TBL] [Abstract][Full Text] [Related]
13. Ineligible, Unaware, or Uninterested? Associations Between Underrepresented Patient Populations and Retention in the Pathway to Cancer Clinical Trial Enrollment.
Caston NE; Lalor F; Wall J; Sussell J; Patel S; Williams CP; Azuero A; Arend R; Liang MI; Rocque GB
JCO Oncol Pract; 2022 Nov; 18(11):e1854-e1865. PubMed ID: 36178922
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?
Jimenez R; Zhang B; Joffe S; Nilsson M; Rivera L; Mutchler J; Lathan C; Paulk ME; Prigerson HG
J Palliat Med; 2013 Mar; 16(3):256-62. PubMed ID: 23384245
[TBL] [Abstract][Full Text] [Related]
15. Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing clinical trial enrollment among ovarian cancer patients.
Greenwade MM; Moore KN; Gillen JM; Ding K; Rowland MR; Crim AK; Kleis B; Gunderson CC
Gynecol Oncol; 2017 Sep; 146(3):465-469. PubMed ID: 28689668
[TBL] [Abstract][Full Text] [Related]
17. Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.
Eggly S; Hamel LM; Heath E; Manning MA; Albrecht TL; Barton E; Wojda M; Foster T; Carducci M; Lansey D; Wang T; Abdallah R; Abrahamian N; Kim S; Senft N; Penner LA
BMC Cancer; 2017 Dec; 17(1):807. PubMed ID: 29197371
[TBL] [Abstract][Full Text] [Related]
18. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
[TBL] [Abstract][Full Text] [Related]
19. Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.
Collins CL; Malvar J; Hamilton AS; Deapen DM; Freyer DR
Cancer; 2015 Dec; 121(24):4398-406. PubMed ID: 26393950
[TBL] [Abstract][Full Text] [Related]
20. Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials.
Jorge S; Masshoor S; Gray HJ; Swisher EM; Doll KM
J Natl Compr Canc Netw; 2023 Jan; 21(1):27-32.e2. PubMed ID: 36634612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
